ArticleInternational wound journal2023

Gene therapy for diabetic foot ulcers: Interim analysis of a randomised, placebo-controlled phase 3 study of VM202 (ENGENSIS), a plasmid DNA expressing two isoforms of human hepatocyte growth factor.

Emerson Perin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.